Botulinum neurotoxins (BoNT) have become a cornerstone in the treatment of hyperkinetic movement disorders, offering targeted and reversible ...

Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −Highlights Phase 2 data for ATH434 in Multiple System ...

UBC Okanagan researchers have advanced their work on developing a non-invasive, accessible way to reduce uncontrolled hand tremors. In a newly published study, the team has demonstrated how a new ...

FDA approvals, trial progress and early commercial momentum put several ASX healthcare companies in a strong position heading ...

The bleeding disorders treatment market is expanding due to increased diagnosis rates and government support, with ...

Untreated thyroid disorders in pregnancy can affect a baby's brain, growth and vision. Experts explain why early screening ...

In every recovery story--whether it is an athlete returning to the field, a senior regaining mobility, or a child taking ...

“To the best of our team's knowledge, this project represents the first time an Alabama medical center has examined deep ...

Patients with CaV2.1 channelopathies face severe and often debilitating symptoms, such as seizures, migraines, tremors, and ...

LIMBR will be a national hub for excellence in multidisciplinary human movement research across the entire lifespan. While ...

Backed by more than 60 years of clinical knowledge, Natus Elite has earned a reputation as the EMG software users trust to help assess patients and perform important research with greater certainty.

Dave Rosa, president and CEO of NeuroOne, joins MobihealthNews for part 2 of the Emerging Technologies series to discuss the ...